Effectiveness of Total Hip Arthroplasty Combined With Hip Braces for Hip Charcot Arthropathy

Abstract

Objective: Charcot arthropathy is characterized by varying degrees of sensory loss and rapidly progressive joint destruction. Historically, limited studies indicated that Charcot arthropathy of the hip joint may be a contraindication for total hip arthroplasty (THA). Yet, some recent studies have shown that good clinical results and acceptable survival rate. Hence, this study aimed to investigate clinical outcomes, radiographic outcomes, complication rates and survivorship of primary THA in Charcot arthropathy.

Methods: We retrospectively included 11 patients (11 hips) with Charcot arthropathy who underwent THA between 1998 and 2016. All involved patients were diagnosed as syphilis. All patients had classic radiographic findings of Charcot arthropathy. The hip braces were used in all patients for six weeks after surgery. Outcome measures included VAS, Oxford Hip Score, and UCLA score. Statistical analyses involved t-tests, chi-square tests, and Kaplan–Meier survival analysis.

Results: The average follow-up period was 81.73 months. The average VAS, Oxford Hip Score, and UCLA score were improved significantly. There was higher complication rate of 45.5% after THA. Reoperation was carried out in two patients due to dislocation and acetabular component loosening. The Kaplan–Meier survivorship with an end point of reoperation for any reason was 81.8%.

Conclusions: THA is proved to be reasonable in improving hip joint function, which is suitable for patients with Charcot hip joint. Although the complication rate is high, we consider that THA combined with hip brace may be a valid treatment choice for Charcot arthropathy with detailed preoperative planning and proper precautions.

Keywords

Charcot arthropathy / complications / hip brace / instability / survivorship / total hip arthroplasty

References

[1] R. Gupta, “A Short History of Neuropathic Arthropathy,” Clinical Orthopaedics and Related Research 296 (1993): 43–49.

[2] D. Inoue, T. Kabata, Y. Kajino, et al., “Clinical Results of Total Hip Arthroplasty in Two Patients With Charcot Hip Joints due to Congenital Insensivity to Pain With Anhydrosis,” Case Reports in Orthopedics 2018 (2018): 1–5.

[3] A. Sudanese, F. Giardina, F. Biondi, F. Traina, F. Bertoni, and A. Toni, “Charcot’s Joint Secondary to Neurologic Complications of Epidural Anaesthesia: A Case Report,” La Chirurgia Degli Organi di Movimento 91 (2008): 159–162.

[4] K. Rąpała and M. Obrębski, “Charcot’s Arthropathy of the Hip Joints: A Late Manifestation of Tabes Dorsalis Successfully Treated by Total Joint Arthroplasty. Report of 2 Cases,” Journal of Arthroplasty 22, no. 5 (2007): 771–774.

[5] M. E. Tibbo, B. P. Chalmers, D. J. Berry, M. W. Pagnano, D. G. Lewallen, and M. P. Abdel, “Primary Total Knee Arthroplasty in Patients With Neuropathic (Charcot) Arthropathy: Contemporary Results,” Journal of Arthroplasty 33, no. 9 (2018): 2815–2820.

[6] M. Kraay and S. Bigach, “The Neuromuscularly Challenged Patient: Total Hip Replacement Is Now an Option,” Bone & Joint Journal 96, no. S11 (2014): 27–31.

[7] D. E. Padgett and H. Warashina, “The Unstable Total Hip Replacement,” Clinical Orthopaedics and Related Research 420 (2004): 72–79.

[8] Y. Ishii, H. Noguchi, M. Takeda, J. Sato, and Y. Domae, “Efficacy of an Abduction Brace in Preventing Initial Dislocation in the Early Postoperative Period After Primary Total Hip Arthroplasty,” 2012 131–135.

[9] B. P. Chalmers, M. E. Tibbo, R. T. Trousdale, D. G. Lewallen, D. J. Berry, and M. P. Abdel, “Primary Total Hip Arthroplasty for Charcot Arthropathy Is Associated With High Complications but Improved Clinical Outcomes,” Journal of Arthroplasty 33, no. 9 (2018): 2912–2918.

[10] M. Erdil, K. Bilsel, Y. Imren, H. H. Ceylan, and I. Tuncay, “Total Hip Arthroplasty in a Patient With Congenital Insensitivity to Pain: A Case Report,” Journal of Medical Case Reports 6 (2012): 1–4.

[11] L. D. Dorr, A. W. Wolf, R. Chandler, and J. P. Conaty, “Classification and Treatment of Dislocations of Total Hip Arthroplasty,” Clinical Orthopaedics and Related Research 173 (1983): 151–158.

[12] G. Goddard, H. Karibe, and C. McNeill, “Reproducibility of Visual Analog Scale (VAS) Pain Scores to Mechanical Pressure,” Cranio 22, no. 3 (2004): 250–256.

[13] J. Dawson, R. Fitzpatrick, A. Carr, and D. Murray, “Questionnaire on the Perceptions of Patients About Total Hip Replacement,” Journal of Bone and Joint Surgery (British Volume) 78, no. 2 (1996): 185–190.

[14] C. A. Zahiri, T. P. Schmalzried, E. S. Szuszczewicz, and H. C. Amstutz, “Assessing Activity in Joint Replacement Patients,” Journal of Arthroplasty 13, no. 8 (1998): 890–895.

[15] C. A. Engh, W. L. Griffin, and C. L. Marx, “Cementless acetabular components,” Journal of Bone and Joint Surgery (British Volume) 72, no. 1 (1990): 53–59.

[16] C.-K. Liaw, S.-M. Hou, R.-S. Yang, T.-Y. Wu, and C.-S. Fuh, “A New Tool for Measuring Cup Orientation in Total Hip Arthroplasties From Plain Radiographs,” Clinical Orthopaedics and Related Research (1976–2007) 451 (2006): 134–139.

[17] C. Khalily and D. K. Lester, “Results of a Tapered Cementless Femoral Stem Implanted in Varus,” Journal of Arthroplasty 17, no. 4 (2002): 463–466.

[18] T. A. Gruen, G. M. McNeice, and H. C. Amstutz, “Modes of Failure of Cemented Stem-Type Femoral Components: A Radiographic Analysis of Loosening,” Clinical Orthopaedics and Related Research 141 (1976): 17–27.

[19] J. G. DeLee and J. Charnley, “Radiological Demarcation of Cemented Sockets in Total Hip Replacement,” Clinical Orthopaedics and Related Research 121 (1976): 20–32.

[20] A. F. Brooker, J. W. Bowerman, R. A. Robinson, and L. H. Riley, Jr., “Ectopic Ossification Following Total Hip Replacement: Incidence and a Method of Classification,” Journal of Bone and Joint Surgery 55, no. 8 (1973): 1629–1632.

[21] S. Noordin, B. A. Masri, C. P. Duncan, and D. S. Garbuz, “Acetabular Bone Loss in Revision Total Hip Arthroplasty: Principles and Techniques,” Instructional Course Lectures 59 (2010): 27–36.

[22] P. H. Hsieh, Y. Chang, D. W. Chen, M. S. Lee, H. N. Shih, and S. W. Ueng, “Pain Distribution and Response to Total Hip Arthroplasty: A Prospective Observational Study in 113 Patients With End-Stage Hip Disease,” Journal of Orthopaedic Science 17, no. 3 (2012): 213–218.

[23] E. A. Jones, B. Manaster, D. A. May, and D. G. Disler, “Neuropathic Osteoarthropathy: Diagnostic Dilemmas and Differential Diagnosis,” Radiographics 20, no. S1 (2000): S279–S293.

[24] S. Lucchini, F. Castagnini, F. Giardina, et al., “Cementless Ceramic-On-Ceramic Total Hip Arthroplasty in Post-Traumatic Osteoarthritis After Acetabular Fracture: Long-Term Results,” Archives of Orthopaedic and Trauma Surgery 141 (2021): 683–691.

[25] Y. Lu, H. Xiao, and F. Xue, “Causes of and Treatment Options for Dislocation Following Total Hip Arthroplasty,” Experimental and Therapeutic Medicine 18, no. 3 (2019): 1715–1722.

[26] J. Queally, A. Abdulkarim, and K. Mulhall, “Total Hip Replacement in Patients With Neurological Conditions,” Journal of Bone and Joint Surgery (British Volume) 91, no. 10 (2009): 1267–1273.

[27] M. Garlicki and R. Kreezko, “Management of Arthrosis Deformans of the Hip Joint,” Ortopediia Travmatologiia i Protezirovanie 33, no. 4 (1972): 29–32.

[28] J. Robb, L. Rymaszewski, B. Reeves, and C. Lacey, “Total Hip Replacement in a Charcot Joint: Brief Report,” Journal of Bone and Joint Surgery (British) 70, no. 3 (1988): 489.

[29] T. N. Gerhart and R. D. Scott, “Hip Arthroplasty in Patients With Tabetic Charcot Joints,” Orthopedics 6, no. 2 (1983): 179–183.

[30] T. R. Sprenger and C. J. Foley, “Hip Replacement in a Charcot Joint: A Case Report and Historical Review,” Clinical Orthopaedics and Related Research 165 (1982): 191–194.

[31] Z. Zhang, J. Chi, J. Raso, H. Xu, and Q. Cui, “Outcomes Following Total Hip Arthroplasty in Patients Who Have Charcot Neuroarthropathy of the Hip,” Journal of Arthroplasty 38, no. 12 (2023): 2650–2654.

[32] A. Dagnino, N. Ursino, C. A. M. Ripamonti, et al., “Total Hip Arthroplasty in an Inveterate Femoral Neck Fracture in a Patient With Congenital Insensitivity to Pain With Anhidrosis,” Joints 5, no. 4 (2017): 249–252.

[33] M. Burman, “The Weight Stream in Charcot Disease of Joints: Charcot Disease of the Hip,” Bulletin of the Hospital for Joint Diseases 17, no. 2 (1956): 386–403.

[34] G. Gualtieri, A. Sudanese, A. Toni, and A. Giunti, “Loosening of a Hip Prosthesis in a Patient Affected With Tabetic Disease,” Chirurgia Degli Organi di Movimento 76, no. 1 (1991): 83–85.

[35] K. Kopec, D. Kusz, L. Cielinski, P. Wojciechowski, and G. Hajduk, “Bilateral Neurogenic Hip Arthropathy,” Neuroendocrinology Letters 30, no. 6 (2009): 709–714.

[36] M. Childs, D. G. Armstrong, and G. W. Edelson, “Is Charcot Arthropathy a Late Sequela of Osteoporosis in Patients With Diabetes Mellitus?,” Journal of Foot and Ankle Surgery 37, no. 5 (1998): 437–439.

[37] H. A. El Oraby, M. M. Abdelsalam, Y. M. Eid, R. El Hilaly, and H. A. Marzouk, “Bone Mineral Density in Type 2 Diabetes Patients With Charcot Arthropathy,” Current Diabetes Reviews 15, no. 5 (2019): 395–401.

[38] K. Hirata, Y. Murata, A. Hatakeyama, M. Takahashi, P. M. Quinn, and S. Uchida, “Biomechanical Analysis of Hip Braces After Hip Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: An Observational Study,” Biomimetics (Basel) 8, no. 2 (2023): 225.

[39] S. T. Woolson and Z. O. Rahimtoola, “Risk Factors for Dislocation During the First 3 Months After Primary Total Hip Replacement,” Journal of Arthroplasty 14, no. 6 (1999): 662–668.

[40] R. Michalik, K. Essing, B. Rohof, M. Gatz, F. Migliorini, and M. Betsch, “Do Hip-Abduction Braces Work?-A Biomechanical Evaluation of a Commercially Available Hip Brace,” Archives of Orthopaedic and Trauma Surgery 142, no. 6 (2022): 1275–12781.

[41] P. M. Pellicci, H. G. Potter, L. F. Foo, and F. Boettner, “MRI Shows Biologic Restoration of Posterior Soft Tissue Repairs After THA,” Clinical Orthopaedics and Related Research 467, no. 4 (2009): 940–945.

RIGHTS & PERMISSIONS

2024 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.